Print Friendly, PDF & Email

Experimental drug given to Trump to treat covid-19 wins FDA clearance:

Topics Covered: Issues related to Health.

Experimental drug given to Trump to treat covid-19 wins FDA clearance:


Context:

Food and Drug Administration has granted emergency authorization to the experimental antibody treatment given to President Trump last month when he developed covid-19, the disease caused by the novel coronavirus.

About the drug:

  • The drug is made by Regeneron Pharmaceuticals.
  • It is a cocktail of two monoclonal antibodies, called casirivimab and imdevimab.
  • It is designed to prevent infected people from developing severe illness.
  • Instead of waiting for the body to develop its own protective immune response, the drug imitates the body’s natural defenses.
  • It is the second drug of this type — called a monoclonal antibody — to be cleared for treating covid-19.

What are monoclonal antibodies?

  • Monoclonal antibodies are proteins that mimic the immune system’s ability to attack the virus.
  • They are man-made proteins.

polyclonal

InstaLinks:

Prelims Link:

  1. What are antibodies?
  2. What are antigens?
  3. How immunity system works in our body?
  4. What are mAbs?
  5. What are Polyclonal antibodies?

Mains Link:

What are monoclonal antibodies? How do they work? Discuss.

Sources: the Hindu.